Ritu Banerjee

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi Streptococcus pneumoniae-associated hemolytic uremic syndrome among children in North America
    Ritu Banerjee
    Department of Pediatrics, Mayo Clinic, Rochester, MN, USA
    Pediatr Infect Dis J 30:736-9. 2011
  2. ncbi Rapid drug susceptibility testing with a molecular beacon assay is associated with earlier diagnosis and treatment of multidrug-resistant tuberculosis in California
    Ritu Banerjee
    Division of Pediatric Infectious Diseases, Mayo Clinic, Rochester, MN 55905, USA
    J Clin Microbiol 48:3779-81. 2010
  3. ncbi A mecA-negative strain of methicillin-resistant Staphylococcus aureus with high-level β-lactam resistance contains mutations in three genes
    Ritu Banerjee
    Division of Pediatric Infectious Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Antimicrob Agents Chemother 54:4900-2. 2010

Detail Information

Publications3

  1. ncbi Streptococcus pneumoniae-associated hemolytic uremic syndrome among children in North America
    Ritu Banerjee
    Department of Pediatrics, Mayo Clinic, Rochester, MN, USA
    Pediatr Infect Dis J 30:736-9. 2011
    ..To better characterize Streptococcus pneumoniae-associated hemolytic-uremic syndrome (SP-HUS), we report the largest series of SP-HUS among children in North America...
  2. ncbi Rapid drug susceptibility testing with a molecular beacon assay is associated with earlier diagnosis and treatment of multidrug-resistant tuberculosis in California
    Ritu Banerjee
    Division of Pediatric Infectious Diseases, Mayo Clinic, Rochester, MN 55905, USA
    J Clin Microbiol 48:3779-81. 2010
    ..Use of the MB assay reduced the time to detection and treatment of MDR TB...
  3. ncbi A mecA-negative strain of methicillin-resistant Staphylococcus aureus with high-level β-lactam resistance contains mutations in three genes
    Ritu Banerjee
    Division of Pediatric Infectious Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Antimicrob Agents Chemother 54:4900-2. 2010
    ..CRB displayed resistance to a variety of β-lactams but was hypersusceptible to cefoxitin...